Gutwerg Ori (CIK 1846478) reported 19 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-13). Recent activity: Sell ANIP (2,772 shares), Sell ANIP (3,314 shares), Sell ANIP (2,060 shares), Buy ANIP (12,969 shares), Sell ANIP (2,221 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-13 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 2,772 | $220,374 |
| 2026-03-10 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 3,314 | $245,369 |
| 2026-03-04 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 2,060 | $157,590 |
| 2026-03-02 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Buy | 12,969 | $1.0M |
| 2026-03-02 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 2,221 | $164,132 |
| 2026-02-17 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 1,775 | $136,142 |
| 2026-02-17 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 1,888 | $146,056 |
| 2026-02-13 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 4,267 | $325,359 |
| 2025-08-14 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 5,873 | $508,191 |
| 2025-05-16 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 881 | $52,922 |
| 2025-03-14 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 3,314 | $200,895 |
| 2025-03-07 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Buy | 300 | $9,447 |
| 2025-03-07 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 300 | $18,009 |
| 2025-03-07 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 5,084 | $305,040 |
| 2025-03-04 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 1,570 | $97,167 |
| 2025-02-18 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Buy | 15,668 | $0 |
| 2025-02-18 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Buy | 10,444 | $0 |
| 2025-02-18 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 1,426 | $84,020 |
| 2025-02-18 | ANI PHARMACEUTICALS INC (ANIP) | SVP, GENERICS | Sell | 1,167 | $68,760 |
Source: SEC Form 4 filings · as of 2026-05-13